Ferenci, P; Brunner, H; Laferl, H; Czizek, U; Rosenbeiger, M; Stauber, R; Maieron, A; Fischer, G; Steindl-Munda, P.
Interim analysis of a randomized, controlled study comparing the efficacy of 40KD peg-interferon alfa2a in combination with 800mg or 400 mg ribavirin/day in chronic hepatitis C, genotype 2/3
GASTROENTEROLOGY. 2005; 128(4): A684-A684.
Web of Science